CART-33

CAR-T cell therapy targeting CD33 · Chinese PLA General Hospital

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CART-33, covering 2016-01-28 to 2016-01-28. Get the full timeline:

Most recent: Clinical Trial Update: Treatment of Relapsed and/or Chemotherapy Refractory CD33 Positive Acute Myeloid Leukemia by CART-33 [Phase 1, Phase 2]

See pricing